JATT II Acquisition
JATT · NASDAQ
$10.33+$0.0272 (+0.26%)TodayMarket closed ·
Prev close $10.30
Who owns JATT
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 69.1% of JATT’s shares.
- Jatt Ventures II LP19.9%
- RA Capital Management, LP6.4%
- Great Point Partners, LLC6.4%
- Balyasny Asset Management LP6.4%
- Next 6 largest institutions30.0%
- All other shareholders30.9%
| Holder | Shares | % of shares |
|---|---|---|
| Jatt Ventures II LP | 1.55M | 19.87% |
| RA Capital Management, LP | 500.00K | 6.41% |
| Great Point Partners, LLC | 500.00K | 6.41% |
| Balyasny Asset Management LP | 500.00K | 6.41% |
| Janus Henderson Investors | 500.00K | 6.41% |
| Adar1 Capital Management LLC | 417.72K | 5.36% |
| Atika Capital Management LLC | 400.00K | 5.13% |
| Franklin Advisers, Inc. | 400.00K | 5.13% |
| Citadel Advisors LLC | 319.99K | 4.10% |
| Farallon Capital Management, L.L.C. | 300.00K | 3.85% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Franklin Templeton Investment Funds -Biotechnology Discovery | 253.25K | 3.25% |
| Franklin Biotechnology Discovery Fund | 146.75K | 1.88% |
| Fidelity NASDAQ Composite Index Fund | 4.38K | 0.06% |
Short interest
Settled Sep 30, 2026
- Shares short
- 5.50K
- Days to cover
- 1.00
- % of shares outstanding
- 0.07%
- Average daily volume
- 56.90K
- Change since last report
- −10.3%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.